Login
$BFNH
$6.10 +$0.23 (3.92%) Close

$BFNH SEC Filings

Filed On Filing
07 Oct 2026 8-K: Other Events

On September 28, 2026, Bioforce Nanoscience, Inc. (“Bioforce” or “BFNH”) (“Assignee”) received an assignment from the State of Texas’ General Land Office (“GLO”) (“Lessor”) on a certain oil and gas property, covering approximately 40.19 ...

04 Sep 2026 SCHEDULE 13D
04 Sep 2026 Form 3: Nexus Capital Investments, Inc., 10% owner

Holds 26,700,000 shares of Common Stock; Par Value $0.001

04 Sep 2026 8-K: Unregistered Sales of Equity Securities
03 Sep 2026 Form 3: Mager Scott, Director

Holds 1,000,000 shares of Common Stock; Par Value $0.001

02 Sep 2026 Form 4: Ferguson Merle, Director

Acquired 24,712,000 shares (Gift) ($148K) · Sold 26,700,000 shares ($401K)

02 Sep 2026 Form 4: Kaiser Richard Kaiser, Director

Gave 4,132,000 shares as a gift ($4.13K) · Disposed of 38,462 shares (Other Transaction) ($25K) · Received 316,909 shares as a grant or award ($174K)

18 Aug 2026 8-K: Regulation FD Disclosure
14 Aug 2026 8-K: Other Events
10 Aug 2026 QTR. REPORT - JUNE 30, 2026
07 Jul 2026 8-K: Other Events
01 Jul 2026 8-K: Other Events
18 Jun 2026 8-K: Changes in Control of Registrant; Departure/Election of Directors or Officers; Compensation +1 more
19 May 2026 QTR. REPORT - MARCH 31, 2026
13 May 2026 NOTIFICATION OF LATE FILING
15 Apr 2026 YEAR- END REPORT - DEC. 31, 2025
31 Mar 2026 NOTIFICATION OF LATE FILING
19 Nov 2025 QTR. REPORT - SEPTEMBER 30, 2025
13 Nov 2025 NOTIFICATION OF LATE FILING
11 Aug 2025 QTR. REPORT - JUNE 30, 2025

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support